Frontiers in Endocrinology (Jun 2022)

A Clinical Predictive Model of Central Lymph Node Metastases in Papillary Thyroid Carcinoma

  • Zipeng Wang,
  • Qungang Chang,
  • Hanyin Zhang,
  • Gongbo Du,
  • Shuo Li,
  • Yihao Liu,
  • Hanlin Sun,
  • Detao Yin,
  • Detao Yin,
  • Detao Yin

DOI
https://doi.org/10.3389/fendo.2022.856278
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundThyroid carcinoma is one of the most common endocrine tumors, and papillary thyroid carcinoma (PTC) is the most common pathological type. Current studies have reported that PTC has a strong propensity for central lymph node metastases (CLNMs). Whether to prophylactically dissect the central lymph nodes in PTC remains controversial. This study aimed to explore the risk factors and develop a predictive model of CLNM in PTC.MethodsA total of 2,554 patients were enrolled in this study. The basic information, laboratory examination, characteristics of cervical ultrasound, genetic test, and pathological diagnosis were collected. The collected data were analyzed by univariate logistic analysis and multivariate logistic analysis. The risk factors were evaluated, and the predictive model was constructed of CLNM.ResultsThe multivariate logistic analysis showed that Age (p < 0.001), Gender (p < 0.001), Multifocality (p < 0.001), BRAF (p = 0.027), and Tumor size (p < 0.001) were associated with CLNM. The receiver operating characteristic curve (ROC curve) showed high efficiency with an area under the ROC (AUC) of 0.781 in the training group. The calibration curve and the calibration of the model were evaluated. The decision curve analysis (DCA) for the nomogram showed that the nomogram can provide benefits in this study.ConclusionThe predictive model of CLNM constructed and visualized based on the evaluated risk factors was confirmed to be a practical and convenient tool for clinicians to predict the CLNM in PTC.

Keywords